Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 3/2019

01-03-2019 | Antibiotic | Original Article

Clinical outcome of pharmacist-led prospective audit with intervention and feedback after expansion from patients using specific antibiotics to those using whole injectable antibiotics

Authors: Kengo Ohashi, Tomoko Matsuoka, Yasutaka Shinoda, Takayuki Mori, Shinya Yoshida, Tomoaki Yoshimura, Tadashi Sugiyama

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2019

Login to get access

Abstract

Prospective audit with intervention and feedback (PAF) and preauthorisation of antimicrobials are core strategies for antimicrobial stewardship (AS). PAF participants were expanded from patients using specific antibiotics to those using whole injectable antibiotics to evaluate clinical outcome. From January 2016 to December 2016, PAF was performed in patients using specific antibiotics (period 1) and from January 2017 to December 2017, PAF was performed in patients using whole injectable antibiotics (period 2). PAF was implemented for 5 days every week by pharmacists involved in infectious diseases chemotherapy. In total, 11,571 and 11,103 patients used antibiotic injections during periods 1 and 2, respectively. No significant difference in mortality within 30 days from the initial use of injection antibiotics was observed. The average duration of hospitalisation was significantly shorter during period 2 among patients using antibiotics; however, this was not significantly different from that of patients not receiving antibiotics. The average duration of therapy for intravenous antibiotics was significantly shorter during period 2 than during period 1. The ratio of methicillin-resistant Staphylococcus aureus (MRSA) to S. aureus was significantly low during period 2. The duration of intravenous antibiotic therapy for Escherichia coli bacteraemia during period 2 decreased significantly. De-escalation and appropriate antimicrobial treatment rates at specific doses during period 2 increased significantly. Expansion of patients eligible for PAF from patients using specific antibiotics to patients using whole injectable antibiotics shortened hospital stays, suppressed drug resistance, and promoted the appropriate use of antibiotics.
Literature
1.
go back to reference Giske CG, Monnet DL, Cars O, Carmeli Y (2008) Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 52:813–821CrossRefPubMed Giske CG, Monnet DL, Cars O, Carmeli Y (2008) Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 52:813–821CrossRefPubMed
2.
go back to reference Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJ (2016) Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387:176–187CrossRefPubMed Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJ (2016) Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387:176–187CrossRefPubMed
3.
go back to reference Niki Y (2017) Guidance for implementing an antimicrobial stewardship program Japan. Jpn J Chemother 65:650–687 Niki Y (2017) Guidance for implementing an antimicrobial stewardship program Japan. Jpn J Chemother 65:650–687
4.
go back to reference Barlam TF, Cosgrove SE, Abbo LM, Macdougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Hamilton CW, Jenkins TC, Lipsett PA, Malani PN, May LS, Moran GJ, Neuhauser MM, Newland JG, Ohl CA, Samore MH, Seo SK, Trivedi KK (2016) Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62:e51–e77CrossRefPubMedPubMedCentral Barlam TF, Cosgrove SE, Abbo LM, Macdougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Hamilton CW, Jenkins TC, Lipsett PA, Malani PN, May LS, Moran GJ, Neuhauser MM, Newland JG, Ohl CA, Samore MH, Seo SK, Trivedi KK (2016) Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62:e51–e77CrossRefPubMedPubMedCentral
5.
go back to reference Johannsson B, Beekmann SE, Srinivasan A, Hersh AL, Laxminarayan R, Polgreen PM (2011) Improving antimicrobial stewardship the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol 32:367–374CrossRefPubMed Johannsson B, Beekmann SE, Srinivasan A, Hersh AL, Laxminarayan R, Polgreen PM (2011) Improving antimicrobial stewardship the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol 32:367–374CrossRefPubMed
6.
go back to reference Fukuda T, Watanabe H, Ido S, Shiragami M (2014) Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 beds --before-after comparative two-year trial in Japan. J Pharm Policy Pract 7:10CrossRefPubMedPubMedCentral Fukuda T, Watanabe H, Ido S, Shiragami M (2014) Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 beds --before-after comparative two-year trial in Japan. J Pharm Policy Pract 7:10CrossRefPubMedPubMedCentral
7.
go back to reference Murakami M, Komatsu H, Sugiyama M, Ichikawa Y, Ide K, Tsuchiya R, Kunieda K, Magishi A, Akiyama G, Miura F, Okada K, Ikezoe M (2018) Antimicrobial stewardship without infectious disease physician for patients with candidemia: a before and after study. J Gen Fam Med 19:82–89CrossRefPubMedPubMedCentral Murakami M, Komatsu H, Sugiyama M, Ichikawa Y, Ide K, Tsuchiya R, Kunieda K, Magishi A, Akiyama G, Miura F, Okada K, Ikezoe M (2018) Antimicrobial stewardship without infectious disease physician for patients with candidemia: a before and after study. J Gen Fam Med 19:82–89CrossRefPubMedPubMedCentral
8.
go back to reference Kimura T, Uda A, Sakaue T, Yamashita K, Nishioka T, Nishimura S, Ebisawa K, Nagata M, Ohji G, Nakamura T, Koike C, Kusuki M, Ioroi T, Mukai A, Abe Y, Yoshida H, Hirai M, Arakawa S, Yano I, Iwata K, Tokimatsu I (2018) Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback. Infection 46:215–224CrossRefPubMed Kimura T, Uda A, Sakaue T, Yamashita K, Nishioka T, Nishimura S, Ebisawa K, Nagata M, Ohji G, Nakamura T, Koike C, Kusuki M, Ioroi T, Mukai A, Abe Y, Yoshida H, Hirai M, Arakawa S, Yano I, Iwata K, Tokimatsu I (2018) Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback. Infection 46:215–224CrossRefPubMed
9.
go back to reference Horikoshi Y, Suwa J, Higuchi H, Kaneko T, Furuichi M, Aizawa Y, Fukuoka K, Okazaki K, Ito K, Shoji T (2017) Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. Int J Infect Dis 64:69–73CrossRefPubMed Horikoshi Y, Suwa J, Higuchi H, Kaneko T, Furuichi M, Aizawa Y, Fukuoka K, Okazaki K, Ito K, Shoji T (2017) Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. Int J Infect Dis 64:69–73CrossRefPubMed
10.
go back to reference Sakeena MHF, Bennett AA, McLachlan AJ (2018) Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review. Antimicrob Resist Infect Control 7:63CrossRefPubMedPubMedCentral Sakeena MHF, Bennett AA, McLachlan AJ (2018) Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review. Antimicrob Resist Infect Control 7:63CrossRefPubMedPubMedCentral
11.
go back to reference Matsuoka T, Kato M, Shinoda Y, Ohashi K, Yoshida S, Mori T, Tachi T, Yoshimura T, Teramachi H (2017) Evaluation of antimicrobial stewardship (AS) for appropriate use of antimicrobial agents. Pharmazie 72:296–299PubMed Matsuoka T, Kato M, Shinoda Y, Ohashi K, Yoshida S, Mori T, Tachi T, Yoshimura T, Teramachi H (2017) Evaluation of antimicrobial stewardship (AS) for appropriate use of antimicrobial agents. Pharmazie 72:296–299PubMed
12.
go back to reference Ohashi K, Matsuoka T, Shinoda Y, Yoshida S, Arai K, Kato M, Mori T, Yoshimura T (2017) Effectiveness of a computer-facilitated, pharmacist-driven antimicrobial stewardship program for infection management. Yakugaku Zasshi 137:643–650CrossRefPubMed Ohashi K, Matsuoka T, Shinoda Y, Yoshida S, Arai K, Kato M, Mori T, Yoshimura T (2017) Effectiveness of a computer-facilitated, pharmacist-driven antimicrobial stewardship program for infection management. Yakugaku Zasshi 137:643–650CrossRefPubMed
13.
go back to reference Government of Japan (2016) National Action Plan on antimicrobial resistance (AMR). The Government of Japan;2016–20 Government of Japan (2016) National Action Plan on antimicrobial resistance (AMR). The Government of Japan;2016–20
14.
go back to reference Chow JW, Yu VL (1999) Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 11:7–12CrossRefPubMed Chow JW, Yu VL (1999) Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 11:7–12CrossRefPubMed
15.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef
16.
go back to reference Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41CrossRefPubMed Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41CrossRefPubMed
17.
go back to reference Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797CrossRefPubMed Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797CrossRefPubMed
18.
go back to reference The Japanese association for infectious diseases, Japanese Society of Chemotherapy. The JAID/JSC guide to clinical management of infectious diseases 2014 The Japanese association for infectious diseases, Japanese Society of Chemotherapy. The JAID/JSC guide to clinical management of infectious diseases 2014
19.
go back to reference Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458CrossRefPubMed Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458CrossRefPubMed
20.
go back to reference Ohashi K, Shinoda Y, Matsuoka T, Yoshida S, Mori T, Hayashi H et al (2018) Evaluation of a prospective audit and feedback intervention by pharmacists for patients receiving intravenous antibiotics. Jpn J Pharm Health Care Sci 44:305–312 Ohashi K, Shinoda Y, Matsuoka T, Yoshida S, Mori T, Hayashi H et al (2018) Evaluation of a prospective audit and feedback intervention by pharmacists for patients receiving intravenous antibiotics. Jpn J Pharm Health Care Sci 44:305–312
21.
go back to reference Niwa T, Shinoda Y, Suzuki A, Ohmori T, Yasuda M, Ohta H, Fukao A, Kitaichi K, Matsuura K, Sugiyama T, Murakami N, Itoh Y (2012) Outcome measurement of extensive implementation of antimicrobial stewardship in patients receiving intravenous antibiotics in a Japanese university hospital. Int J Clin Pract 66:999–1008CrossRefPubMedPubMedCentral Niwa T, Shinoda Y, Suzuki A, Ohmori T, Yasuda M, Ohta H, Fukao A, Kitaichi K, Matsuura K, Sugiyama T, Murakami N, Itoh Y (2012) Outcome measurement of extensive implementation of antimicrobial stewardship in patients receiving intravenous antibiotics in a Japanese university hospital. Int J Clin Pract 66:999–1008CrossRefPubMedPubMedCentral
22.
go back to reference Dunn K, O’Reilly A, Silke B, Rogers T, Bergin C (2011) Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study. Int J Clin Pharm 33:208–214CrossRefPubMed Dunn K, O’Reilly A, Silke B, Rogers T, Bergin C (2011) Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study. Int J Clin Pharm 33:208–214CrossRefPubMed
23.
go back to reference Macheda G, Dyar OJ, Luc A, Beovic B, Béraud G, Castan B, Gauzit R, Lesprit P, Tattevin P, Thilly N, Pulcini C (2018) ESGAP and SPILF. Are infection specialists recommending short antibiotic treatment durations? An ESCMID international cross-sectional survey. J Antimicrob Chemother 73:1084–1090CrossRefPubMed Macheda G, Dyar OJ, Luc A, Beovic B, Béraud G, Castan B, Gauzit R, Lesprit P, Tattevin P, Thilly N, Pulcini C (2018) ESGAP and SPILF. Are infection specialists recommending short antibiotic treatment durations? An ESCMID international cross-sectional survey. J Antimicrob Chemother 73:1084–1090CrossRefPubMed
24.
go back to reference Shen J, Sun Q, Zhou X, Wei Y, Qi Y, Zhu J, Yan T (2011) Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital. Int J Clin Pharm 33:929–933CrossRefPubMed Shen J, Sun Q, Zhou X, Wei Y, Qi Y, Zhu J, Yan T (2011) Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital. Int J Clin Pharm 33:929–933CrossRefPubMed
25.
go back to reference Lawes T, Lopez-Lozano JM, Nebot CA, Macartney G, Subbarao-Sharma R, Dare CR, Wares KD, Gould IM (2015) Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study. Lancet Infect Dis 15:1438–1449CrossRefPubMed Lawes T, Lopez-Lozano JM, Nebot CA, Macartney G, Subbarao-Sharma R, Dare CR, Wares KD, Gould IM (2015) Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study. Lancet Infect Dis 15:1438–1449CrossRefPubMed
26.
go back to reference Ohashi K, Matsuoka T, Shinoda Y, Fukami Y, Shindoh J, Yagi T, Yoshimura T, Sugiyama T (2018) Evaluation of treatment outcomes of patients with MRSA bacteremia following antimicrobial stewardship programs with pharmacist intervention. Int J Clin Pract 72:e13065CrossRefPubMed Ohashi K, Matsuoka T, Shinoda Y, Fukami Y, Shindoh J, Yagi T, Yoshimura T, Sugiyama T (2018) Evaluation of treatment outcomes of patients with MRSA bacteremia following antimicrobial stewardship programs with pharmacist intervention. Int J Clin Pract 72:e13065CrossRefPubMed
27.
go back to reference Howard P, Pulcini C, Levy Hara G, West RM, Gould IM, Harbarth S, Nathwani D (2014) ESCMID Study Group for Antimicrobial Policies (ESGAP); ISC Group on Antimicrobial Stewardship. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother 70:1245–1255PubMed Howard P, Pulcini C, Levy Hara G, West RM, Gould IM, Harbarth S, Nathwani D (2014) ESCMID Study Group for Antimicrobial Policies (ESGAP); ISC Group on Antimicrobial Stewardship. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother 70:1245–1255PubMed
28.
go back to reference Wintenberger C, Guery B, Bonnet E, Castan B, Cohen R, Diamantis S, Lesprit P, Maulin L, Péan Y, Peju E, Piroth L, Stahl JP, Strady C, Varon E, Vuotto F, Gauzit R (2017) Recommendation group of the SPILF. Proposal for shorter antibiotic therapies. Med Mal Infect 47:92–141CrossRefPubMed Wintenberger C, Guery B, Bonnet E, Castan B, Cohen R, Diamantis S, Lesprit P, Maulin L, Péan Y, Peju E, Piroth L, Stahl JP, Strady C, Varon E, Vuotto F, Gauzit R (2017) Recommendation group of the SPILF. Proposal for shorter antibiotic therapies. Med Mal Infect 47:92–141CrossRefPubMed
29.
go back to reference Doi A, Morimoto T, Iwata K (2018) Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study. Clin Microbiol Infect 24:1184–1189CrossRefPubMed Doi A, Morimoto T, Iwata K (2018) Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study. Clin Microbiol Infect 24:1184–1189CrossRefPubMed
30.
go back to reference Nelson AN, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN (2017) Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection 45:613–620CrossRefPubMed Nelson AN, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN (2017) Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection 45:613–620CrossRefPubMed
Metadata
Title
Clinical outcome of pharmacist-led prospective audit with intervention and feedback after expansion from patients using specific antibiotics to those using whole injectable antibiotics
Authors
Kengo Ohashi
Tomoko Matsuoka
Yasutaka Shinoda
Takayuki Mori
Shinya Yoshida
Tomoaki Yoshimura
Tadashi Sugiyama
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Keyword
Antibiotic
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2019
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-03465-z

Other articles of this Issue 3/2019

European Journal of Clinical Microbiology & Infectious Diseases 3/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.